Controlled drug delivery systems: past forward and future back.

[1]  Yoshinori Yamamoto.  Preface , 1994, Nihon Hoshasen Gijutsu Gakkai zasshi.

[2]  J. Feijen,et al.  The Third Symposium on Innovative Polymers for Controlled Delivery, September 16-19, 2014, Suzhou, China. Preface. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Piero Marchetti,et al.  Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution. , 2014, Advanced drug delivery reviews.

[4]  Kinam Park.  Lessons learned from thermosensitive liposomes for improved chemotherapy. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Seiji Miura,et al.  Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[6]  D. Grainger,et al.  The 16th International Symposium on Recent Advances in Drug Delivery, February 3-6, 2013, Salt Lake City, UT, USA. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Tonglei Li,et al.  Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[8]  T. Minko,et al.  Preface-tenth international nanomedicine and drug delivery symposium (NanoDDS'12). , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Kinam Park,et al.  Facing the truth about nanotechnology in drug delivery. , 2013, ACS nano.

[10]  J. Schulzke,et al.  Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa: a first in vivo study in human patients. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[11]  J. Feijen,et al.  The second symposium on innovative polymers for controlled delivery, September 11-14, 2012, Suzhou, China. Preface. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[12]  Johan F J Engbersen.  The 12th edition of the European Symposium on Controlled Drug Delivery, (ESCDD2012) April 4-6, 2012, Egmond aan Zee, The Netherlands. Preface. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Alexander Wei,et al.  Preface: insights into an unsolved problem in drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Kinam Park,et al.  Analysis on the current status of targeted drug delivery to tumors. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[15]  T. Lammers.  Drug delivery research in Europe. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Y. Barenholz.  Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Y. Barenholz,et al.  Liposomes and other assemblies as drugs and nano-drugs: from basic and translational research to the clinics. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Ashish Ranjan,et al.  Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[19]  T. Park,et al.  Novel cell-specific and pH-sensitive non-viral gene carrier system. Preface. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Kinam Park,et al.  Targeted drug delivery to tumors: myths, reality and possibility. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[21]  Zhiyuan Zhong,et al.  Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[22]  A. Kikuchi,et al.  Recent advancements of DDS research in Japan. Editorial. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[23]  T. Scharnweber,et al.  Laser modulated transmembrane convection: Implementation in cancer chemotherapy. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Ping I. Lee,et al.  Evolution of Oral Controlled Release Dosage Forms , 2010 .

[25]  M Ferrari,et al.  Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Kinam Park,et al.  Pharmaceutical nanotechnology: Unmet needs in drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Thomas Günther.  Editorial , 2009, Document Numérique.

[28]  Hyesung Jeon,et al.  Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Felix Kratz,et al.  Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Mark R Prausnitz,et al.  Coated microneedles for transdermal delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Takuro Niidome,et al.  PEG-modified gold nanorods with a stealth character for in vivo applications. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[32]  Marie-Hélène Dufresne,et al.  Block copolymer micelles: preparation, characterization and application in drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[33]  Hua Ai,et al.  Micellar carriers based on block copolymers of poly(ε-caprolactone) and poly(ethylene glycol) for doxorubicin delivery , 2004 .

[34]  D. Fischer,et al.  Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[35]  John Layman,et al.  Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Y Wang,et al.  Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[37]  E. W. Meijer,et al.  Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[38]  S. Davis,et al.  PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[39]  R. Mumper,et al.  Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[40]  H. Bunjes,et al.  Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential , 1997 .

[41]  Gerrit Borchard,et al.  The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro , 1996 .

[42]  M. Hashida,et al.  In vitro cytotoxicity of macromolecules in different cell culture systems , 1995 .

[43]  Teruo Okano,et al.  Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-Adriamycin conjugates , 1994 .

[44]  Yokoyama Masayuki,et al.  Block copolymer micelles as vehicles for drug delivery , 1993 .

[45]  Alexander V. Kabanov,et al.  A new class of drug carriers: micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood in brain☆ , 1992 .

[46]  L. Dong,et al.  A novel approach for preparation of pH-sensitive hydrogels for enteric drug delivery , 1991 .

[47]  Thomas R. Tice,et al.  Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches , 1990 .

[48]  L. Brannon-Peppas,et al.  Solute and penetrant diffusion in swellable polymers. IX: The mechanisms of drug release from pH-sensitive swelling-controlled systems , 1989 .

[49]  R. Siegel,et al.  pH-Controlled release from hydrophobic/polyelectrolyte copolymer hydrogels , 1988 .

[50]  Nicholas A. Peppas,et al.  A simple equation for description of solute release II. Fickian and anomalous release from swellable devices , 1987 .

[51]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[52]  Allan S. Huffman,et al.  Thermally reversible hydrogels: II. Delivery and selective removal of substances from aqueous solutions , 1986 .

[53]  Nicholas A. Peppas,et al.  Solute and penetrant diffusion in swellable polymers. II. Verification of theoretical models , 1986 .

[54]  Nicholas A. Peppas,et al.  Solute and penetrant diffusion in swellable polymers. IV. Semicrystalline, swelling-controlled release systems of poly(ethylene-co-vinyl alcohol) , 1986 .

[55]  R. Gurny,et al.  Ocular therapy with nanoparticulate systems for controlled drug delivery , 1985 .

[56]  Nikolaos A. Peppas,et al.  Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues , 1985 .

[57]  M. Ueda,et al.  Conjugation of poly(styrene-co-maleic acid) derivatives to the antitumor protein neocarzinostatin: pronounced improvements in pharmacological properties. , 1985, Journal of medicinal chemistry.

[58]  Nagai Tsuneji,et al.  Powder dosage form of insulin for nasal administration , 1984 .

[59]  Helfand Wh,et al.  Evolution of pharmaceutical oral dosage forms. , 1983 .

[60]  D. Cowen,et al.  Evolution of pharmaceutical oral dosage forms. , 1983, Pharmacy in history.

[61]  J. Kreuter,et al.  In vitro studies of poly(methyl methacrylate) adjuvants. , 1976, Journal of pharmaceutical sciences.